For research use only. Not for therapeutic Use.
Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.
| Catalog Number | I047381 |
| Purity | ≥95% |
| Reference | [1] Dalakas MC, et al. Ther Adv Neurol Disord. 2021 Feb 26;14:1756286421997381. |
